Tiotropium Bromide Additional Feature: With Inhaler, Composition: Associated With Olodaterol, Concentration: 2.5 Mcg/Dose + 2.5 Mcg/Dose, Pharmaceutical Form: Solution For Inhalation Tiotropium Bromide 2.5 Mcg + Olodaterol 2.5 Mcg, Umeclidinium Bromide Additional: With Inhaler, Composition: Associated With Vilanterol Trifenatate, Concentration: 62.5 Mcg/Dose + 25 Mcg/Dose, Pharmaceutical Form: Inhalant Powder Umeclidinium Bromide 62.5 Mcg + Vilanterol Trifenatate 25 Mcg - 30 Doses, Additional Dapagliflozin: Prolonged Release, Composition: Associated With Saxagliptin, Concentration: 10 Mg + 5, Duloxetine Concentration: 60, Pharmaceutical Form: Slow Release Microgranules, Methylphenidate Hydrochloride Dosage: 18, Pharmaceutical Form: Controlled Release, 28/11/2025 - 13:45:56, Empagliflozin Concentration: 10, Additional Selenium: Specially Manipulated Formulation, Composition: Associated With Zinc Chelate, Concentration: 6 Mg/Ml + 4, Pharmaceutical Form: Oral Solution Vitamin Supplement With Zinc + Magnesium + Selenium And Associations, Lisdexamfetamine Dimesylate Concentration: 50, Escitalopram Oxalate Concentration: 20, Pharmaceutical Form: Orodispersible, Valsartan Composition: Associated With Hydrochlorothiazide, Amlodipine Besylate, Concentration: 320 Mg + 25 Mg + 10, Additional Olanzapine: Orodispersible, Concentration: 5, Lisdexamfetamine Dimesylate Concentration: 40, Pharmaceutical Form: Oral Solution - Drops, Valganciclovir Hydrochloride Dosage: 450, Additional Zolpidem: Sublingual, Concentration: 10, Risperidone Dosage: 1, Pregabalin Concentration: 150, Lamotrigine Concentration: 25, Pharmaceutical Form: Dispersible Tablet, Vortioxetine Composition: Hydrobromide Salt, Empagliflozin Composition: Associated With Linagliptin, Concentration: 25 Mg + 5
